BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24781871)

  • 21. Correlation of Delta-like ligand 4 (DLL4) with VEGF and HIF-1α expression in human glioma.
    Li Z; Wang J; Gong L; Wen Z; Xu C; Huang X
    Asian Pac J Cancer Prev; 2011; 12(1):215-8. PubMed ID: 21517260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of [
    Rainer E; Wang H; Traub-Weidinger T; Widhalm G; Fueger B; Chang J; Zhu Z; Marosi C; Haug A; Hacker M; Li S
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2396-2403. PubMed ID: 30062604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas.
    Suzuki K; Kawai N; Ogawa T; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T
    EJNMMI Res; 2021 Jul; 11(1):67. PubMed ID: 34291337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DCE-MRI in Human Gliomas: A Surrogate for Assessment of Invasive Hypoxia Marker HIF-1Α Based on MRI-Neuronavigation Stereotactic Biopsies.
    Xie Q; Wu J; Du Z; Di N; Yan R; Pang H; Jin T; Zhang H; Wu Y; Zhang Y; Yao Z; Feng X
    Acad Radiol; 2019 Feb; 26(2):179-187. PubMed ID: 29754996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
    J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    Muzi M; Peterson LM; O'Sullivan JN; Fink JR; Rajendran JG; McLaughlin LJ; Muzi JP; Mankoff DA; Krohn KA
    J Nucl Med; 2015 Aug; 56(8):1223-8. PubMed ID: 26112020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of [
    Jiang H; Zhang R; Jiang H; Zhang M; Guo W; Feng G; Pan W; Xu H; Wang S
    Nucl Med Biol; 2019; 72-73():36-44. PubMed ID: 31330410
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Patel CB; Fazzari E; Chakhoyan A; Yao J; Raymond C; Nguyen H; Manoukian J; Nguyen N; Pope W; Cloughesy TF; Nghiemphu PL; Czernin J; Lai A; Ellingson BM
    J Neurooncol; 2018 Sep; 139(2):399-409. PubMed ID: 29679199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor.
    Toyonaga T; Yamaguchi S; Hirata K; Kobayashi K; Manabe O; Watanabe S; Terasaka S; Kobayashi H; Hattori N; Shiga T; Kuge Y; Tanaka S; Ito YM; Tamaki N
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):611-619. PubMed ID: 27752745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.
    Shibahara I; Kumabe T; Kanamori M; Saito R; Sonoda Y; Watanabe M; Iwata R; Higano S; Takanami K; Takai Y; Tominaga T
    J Neurosurg; 2010 Aug; 113(2):358-68. PubMed ID: 19895196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between hypoxic area in primary brain tumors and WHO grade: differentiation from malignancy using 18F-fluoromisonidazole positron emission tomography.
    Kanoto M; Kirii K; Hiraka T; Toyoguchi Y; Sugai Y; Matsuda K; Sakurada K; Sonoda Y; Hatazawa J; Hosoya T
    Acta Radiol; 2018 Feb; 59(2):229-235. PubMed ID: 28534419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM; Li DC; Zhang ZX; Zhang XY
    Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxic volume evaluated by
    Sato J; Kitagawa Y; Watanabe S; Asaka T; Ohga N; Hirata K; Shiga T; Satoh A; Tamaki N
    Int J Oral Maxillofac Surg; 2018 May; 47(5):553-560. PubMed ID: 29030021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.
    Löck S; Linge A; Seidlitz A; Bandurska-Luque A; Nowak A; Gudziol V; Buchholz F; Aust DE; Baretton GB; Zöphel K; Steinbach J; Kotzerke J; Overgaard J; Zips D; Krause M; Baumann M; Troost EGC
    Radiother Oncol; 2019 Jun; 135():43-50. PubMed ID: 31015169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.
    Sato J; Kitagawa Y; Yamazaki Y; Hata H; Asaka T; Miyakoshi M; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2031-41. PubMed ID: 24867258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of hypoxia as measured by fluorine-18 fluoroerythronitroimidazole (
    Hu M; Zhu Y; Mu D; Fan B; Zhao S; Yang G; Ma L; Zheng J; Yu J
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1427-1434. PubMed ID: 31776634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing hypoxia in human glioma: A simultaneous multimodal MRI and PET study.
    Preibisch C; Shi K; Kluge A; Lukas M; Wiestler B; Göttler J; Gempt J; Ringel F; Al Jaberi M; Schlegel J; Meyer B; Zimmer C; Pyka T; Förster S
    NMR Biomed; 2017 Nov; 30(11):. PubMed ID: 28805936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model.
    Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL
    J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.